Rose Higgins


Chief Executive Officer

Rose has spent her career driving innovation in healthcare, from roles in clinical practice to technology companies. She is committed to finding new ways to leverage technology in delivering better health outcomes.

Prior to Dr.Evidence, Rose was CEO of HealthMyne, a pioneering radiomics company whose IP and technology assets were acquired by Genentech (a Roche company) in 2022. She began her career in nursing at the University of Pittsburgh Medical Center, followed by advancing roles in clinical and care management. Transitioning to leadership in healthcare IT organizations, Higgins took on executive roles with increasing responsibility in organizations including McKesson Corporation and SCIO Health Analytics (acquired by EXL Service Holdings) over a successful 20-year period.

Rose received her Bachelor of Science in Nursing from Duquesne University, and her Master of Public Management from Carnegie Mellon University.



Todd Feinman


Chief Medical Officer, Co-Founder

Todd is dedicated to helping develop AI-enabled technologies that will enable anyone, including patients and doctors, to use real data to make informed healthcare decisions. Todd completed his internship at Cedars-Sinai Medical Center in Los Angeles, and his residency in Internal Medicine at Huntington Memorial Hospital in Pasadena, California. Todd specialized in Hospitalist Medicine, and he helped develop the first Hospitalist programs at FHP Hospital, Queen of the Valley Hospital and Cedars-Sinai Medical Group.

Todd received a BS from UCLA and an MD from UCLA School of Medicine. 


Rob Gibson

Chief Technology Officer

Rob is an accomplished software and product executive, with over 16 years of experience in health technology, and over 25 in software development. Throughout his career, he has created compelling new products and transformed health systems.
Prior to joining Dr. Evidence, Rob worked on clinical decision support systems at Elsevier, a global information analytics company, where he focused on improving oncology and primary care patient outcomes around the globe, and led software engineering for India’s DIISHA program, the world’s largest healthcare pilot.

Rob began his career at Sun Microsystems as an engineer on the Solaris operating system, before moving to McKesson, where he worked in the hospitals and health systems division, overseeing the migration of community and critical access hospital EHRs to Microsoft Azure. After the division was acquired by Allscripts, Rob oversaw solutions management for the EHR and population health portfolios, creating consistent business practices that produced predictable bookings and revenue results.

Rob received both his Bachelor of Science, Computer Science, and Master of Business Administration from Colorado State University.


Duane Smulling

Chief Growth Officer

Duane’s career has been dedicated to introducing innovative machine learning and AI-driven technologies to the healthcare industry to optimize care and improve outcomes. With over three decades of experience, he has a passion for applying clinical data and cutting-edge analytics to serve patients through the pharmaceutical, biotech, and health systems sectors. He most recently served as Senior Vice President, Sales at Atomo, a leading technology solutions provider applying machine learning and AI to identify undiagnosed patients that needed care. Beyond his tenure at Atomo, Duane has held senior leadership sales and account development roles at HealthMyne, IPM.ai, EXL Health, Doximity, Veeva, and Qforma. He has successfully partnered with Business Intelligence, Health Outcomes and Commercial leaders at small, mid-size and top 20 life science companies.

Duane earned a business degree from Temple University, and a master’s degree in organizational leadership from Cairn University.


Cathy Finley

Senior Vice President, Marketing & Product Management

Cathy is committed to enabling a more equitable healthcare system through technology. A strategic and operational marketing leader, Cathy is responsible for understanding market needs, building awareness and credibility, generating demand, and enhancing client engagement, collaborating with colleagues across Dr.Evidence. With experience from the Fortune 100 to start-ups, including a foundation in consumer products with P&L responsibility at Procter & Gamble, Cathy brings passion and positivity to her role, focusing on empowering everyone with the evidence to make more informed healthcare decisions.

Cathy holds a BBA in Marketing from the University of Texas and an MBA from Purdue University.


Ivan Lara

Vice President, Finance

Ivan Lara has over 11 years of finance and accounting experience. He is responsible for the company’s finance department which includes financial planning & analysis, reporting, accounting, tax, and internal audit. Prior to Doctor Evidence Ivan spent most of his career helping high-growth technology organizations develop and scale.

Ivan received a Bachelor of Science in Accounting from California Lutheran University.